1,4-dihydroxyanthraquinone has been researched along with alizarin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Matsuda, H; Morikawa, T; Shimoda, H; Yoshikawa, M | 1 |
| Dhananjeyan, MR; Kron, MA; Milev, YP; Nair, MG | 1 |
| Czarny, A; Frackowiak, A; Gancarz, R; Gaweł, W; Skibiński, P; Zaczyńska, E | 1 |
| Inui, K; Kanamitsu, K; Katayama, W; Kitakami, R; Mizuguchi, M; Nakagawa, S; Nakagawa, Y; Okada, T; Sawai, Y; Toyooka, N; Yokoyama, T | 1 |
| Fink, RC; Liberman, DF; Mulcahy, RJ; Schaefer, FL; Stark, AA | 1 |
| Badria, FA; Ibrahim, AS | 1 |
| Aktumsek, A; Alpsoy, L; Degirmenci, NS; Zengin, G | 1 |
1 review(s) available for 1,4-dihydroxyanthraquinone and alizarin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
7 other study(ies) available for 1,4-dihydroxyanthraquinone and alizarin
| Article | Year |
|---|---|
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
Topics: Anthraquinones; Cell Division; Cells, Cultured; Emodin; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Genistein; Humans; Isoflavones; Phytoestrogens; Plant Preparations; Polygonaceae; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship | 2001 |
Synthesis and activity of substituted anthraquinones against a human filarial parasite, Brugia malayi.
Topics: Animals; Anthraquinones; Brugia malayi; Embryo, Nonmammalian; Female; Filaricides; Humans; In Vitro Techniques; Larva; Male; Structure-Activity Relationship | 2005 |
Synthesis of glycoside derivatives of hydroxyanthraquinone with ability to dissolve and inhibit formation of crystals of calcium oxalate. Potential compounds in kidney stone therapy.
Topics: Animals; Anthraquinones; Calcium Oxalate; Cell Line; Glycosides; Humans; Kidney Calculi; Mice; Molecular Structure; Solubility | 2010 |
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
Topics: Amyloid Neuropathies, Familial; Anthraquinones; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Xanthones | 2021 |
Mutagenicity of anthraquinone and hydroxylated anthraquinones in the Ames/Salmonella microsome system.
Topics: Anthracenes; Anthraquinones; Microsomes; Mutagenicity Tests; Mutagens; Salmonella; Structure-Activity Relationship | 1982 |
Evaluation of natural anthracene-derived compounds as antimitotic agents.
Topics: Anthracenes; Anthraquinones; Antimitotic Agents; Antineoplastic Agents; Dose-Response Relationship, Drug; Emodin; Mitosis; Onions; Plant Roots; Time Factors | 2013 |
Evaluation of antioxidant, enzyme inhibition, and cytotoxic activity of three anthraquinones (alizarin, purpurin, and quinizarin).
Topics: Animals; Anthraquinones; Antioxidants; Biological Assay; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Food Additives; Inhibitory Concentration 50; Mice | 2016 |